Presentation from OIS@ASCRS 2017 Sarah Cannon, VP, Global Marketing

1. John Kilcoyne
President & CEO

2. Raindrop Launch Strategy

3. RVO 417 Rev 1 14 of 14

4. Surgeon/Site Selection

5. Presbyopic Market …The Holy Grail
Presbyopic Emmetrope
+1.0 D to -0.5 D
28.5 Million Patients in US
13.1 Million Patients
With a HHI > $75k in US

6. Contrary To Popular Belief
2%
1%
26%
34%
37%
Unsure
Other
Current Optometrist
Current Ophthalmologist
Eye Care Professional
Specializing In Procedure
71% Would Seek An Ophthalmologist
RVO 417 Rev 1 12 of 14

7. Surgeon Growth Opportunity
350 Surgeons Identified

8. Real World Raindrop Outcomes
99% < 20/20
Binocular Distance
N: 149
78% < J3
Binocular Near
N: 173
2.5% Explant Rate

9. Surgeon Satisfaction – Q1 2017
Satisfied Not Satisfied
93%
7
N: 93

10. Surgeon-Surgeon Recommendation – Q1 2017
Recommend Not Recommend
3
97%
N: 93

11. Patient Satisfaction - HealthLoop
How Satisfied Are You With Your Raindrop Vision?
82%
18%
3 Months
Satisfied Dissatisfied
N = 28

12. Patient Recommendation - HealthLoop
Have You Recommended Raindrop To Anyone?
65%
35%
3 Months
YES NO
N = 26

13. Raindrop Reorder Rate
60%
40%
All Accounts
August - March
Reordered
6…
34%
Q1 2017
Vs. August - December

14. Raindrop Launch Strategy...

15. Raindrop… Cracking The Code